NBP (NBP) Stock Price & Analysis
NBP (NBP) rose 1.92% to USD 1.59 as of June 10, 2026 at 02:16 UTC, according to Nexqual real-time market data.
NBP last closed at USD 1.56; the session ranged USD 1.52–1.64 on volume of 401,606 shares. Market capitalization is $183.88M, with a 52-week range of USD 1.52–6.79 (NGM). Source: Nexqual, June 10, 2026 at 02:16 UTC.
Key Statistics (as of June 10, 2026 at 02:16 UTC)
| Price | USD 1.59 |
|---|---|
| Change | ▲ 1.92% (up) |
| Previous Close | USD 1.56 |
| Open | USD 1.61 |
| Day Range | USD 1.52 – 1.64 |
| 52-Week Range | USD 1.52 – 6.79 |
| Volume | 401,606 shares |
| Market Cap | $183.88M |
| Exchange | NGM |
Technical Analysis (NBP)
Nexqual's technical model rates NBP "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:16 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 27.01 (oversold) |
| vs SMA50 | Below (USD 2.17) |
| MACD | -0.17 (negative) |
Analyst Ratings (NBP)
Wall Street analysts rate NBP "None" based on 3 analysts, with a mean price target of USD 8 (range USD 7–9), per Nexqual as of June 10, 2026 at 02:16 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 8 |
| High Target | USD 9 |
| Low Target | USD 7 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (NBP)
| Next Earnings Date | 2026-06-09 |
|---|---|
| EPS Estimate | USD -0.23 |
| Revenue Estimate | $0 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -0.31 vs est -0.08 ▼ miss |
| 2025-09-30 | USD -0.06 vs est -0.05 ▼ miss |
| 2025-06-30 | USD -0.07 vs est -0.12 ▲ beat |
| 2025-03-31 | USD -0.04 vs est -0.07 ▲ beat |
Source: Nexqual, June 10, 2026 at 02:16 UTC.
Financials & Fundamentals (NBP)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -40.89% |
| Debt / Equity | 1.33 |
| Current Ratio | 8.09 |
| Total Cash | $210.84M |
| Total Debt | $3.07M |
| Free Cash Flow | $-37.11M |
Source: Nexqual, June 10, 2026 at 02:16 UTC.
Financial Health Score (NBP)
Nexqual rates NBP's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:16 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $211M cash vs $3M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$21M |
| Efficiency | Critical — ROE -41%, ROA -24.9% |
Ownership (NBP)
| Insider Ownership | +21.33% |
|---|---|
| Institutional Ownership | +39.90% |
| Shares Outstanding | 115.65M |
| Float | 64.49M |
| Short % of Float | +6.89% |
Source: Nexqual, June 10, 2026 at 02:16 UTC.
Leadership (NBP)
NBP is led by Xi-Yong Fu (age 53), CEO & Director, per Nexqual as of June 10, 2026 at 02:16 UTC.
| CEO & Director | Xi-Yong Fu (age 53) |
|---|---|
| Executive Chairman | Wei Fu (age 42) |
| Chief Financial Officer | Ming Lei (age 28) |
| Chief Business Development Officer & Director | Sean Wuxiong Cao (age 58) |
| President & Chief Commercial Officer | Mark Hagler |
Major Backers & Investors (NBP)
Notable institutional backers of NBP include Janus Henderson Group PLC, HHLR Advisors, LTD, Morgan Stanley, according to Nexqual as of June 10, 2026 at 02:16 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Janus Henderson Group PLC | 5.22% |
| HHLR Advisors, LTD | 5.17% |
| Morgan Stanley | 3.32% |
| Siren, L.L.C. | 2.59% |
| Aihc Capital Management Ltd | 1.96% |
| Point72 Asset Management, L.P. | 1.2% |
| Candriam S.C.A. | 0.98% |
| Adage Capital Partners GP L.L.C. | 0.86% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 1% |
Source: Nexqual, June 10, 2026 at 02:16 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ZLAB | Zai Lab Limited | USD 16.65 | ▲ 0.18% |
| ALXO | ALX Oncology Holdings Inc. | USD 1.55 | ▲ 0.65% |
| BNR | Burning Rock Biotech Limited | USD 8.18 | ▼ 11.18% |
| LEGN | Legend Biotech Corporation | USD 33.49 | ▲ 2.67% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | USD 3.58 | ▼ 2.19% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:16 UTC. This page is informational and not investment advice.